G laucoma is a group of eye disorders characterized by progressive degeneration of the optic nerve. This degenerative change results in peripheral and central visual loss 1 and is the second leading cause of blindness worldwide. It has been estimated that the disease affects 66.8 million people, and 6.7 million of these have bilateral blindness. 2 A cross-sectional population study showed that glaucoma is the major cause of blindness among adult Chinese, and primary open-angle glaucoma (POAG) is the predominant form of the disease. 3 Although the molecular basis of POAG is not completely known, it is probably a genetically heterogeneous disorder attributed to the interaction of multiple genes and environment influences. 4, 5 Risk factors like family history, age, smoking, and myopia are also implicated in the pathogenesis of POAG. 6, 7 Six chromosomal loci, GLC1A, GLC1B, GLC1C, GLC1D, GLC1E, and GLC1F, were found to link with POAG. 8 -10 The first gene identified with mutations that cause POAG was MYOC. 11, 12 In whites, approximately 2% to 4% of POAG cases are due to MYOC mutations, [13] [14] [15] although it can be as high as 36% in families with juvenile hereditary POAG. 16 In Japanese, the frequency of MYOC mutations in adult-onset POAG range similarly-approximately 3% to 4%. 17 An intriguing finding in our previous screening of the MYOC gene in Chinese was that the mutation pattern was very different from that in other populations. 18, 19 Recently, the candidate gene for GLC1E on the short arm of chromosome 10, region p14-p15 has been identified as optineurin (OPTN). Mutations in OPTN have been found in approximately 17% of families with hereditary and adult-onset POAG, most of whom had intraocular pressure (IOP) less than 22 mm Hg and a small proportion with moderate IOP between 22 and 26 mm Hg. 20 The OPTN gene consists of 3 noncoding exons in the 5Ј untranslated region and 13 exons that code for a 577-amino-acid protein. It is also known as FIP2 (14.7-kDa interacting protein) 21 and NEMO-related protein (NRP). 22 It was found to interact with Huntingtin protein, 23 transcription factor IIIA, 24 and RAB8. 25 Expression of the human OPTN transcript had been found in ocular tissues, retina, trabecular meshwork, and nonpigmented ciliary epithelium, 20 as well as nonocular tissues, such as heart, brain, placenta, liver, and skeletal muscle. 20, 21 OPTN is also present in aqueous humor of a wide variety of species including humans, cattle, pigs, goats, and sheep, suggesting it to be a secreted protein. 20 In this study, we sought to identify sequence alterations of OPTN in the Chinese population and their association with POAG and corresponding clinical features.
SUBJECTS AND METHODS

Case and Control Study Subjects
Unrelated patients with POAG were recruited from the Eye Clinic of the Prince of Wales Hospital, Hong Kong. Diagnosis was based on meeting all the following criteria: exclusion of secondary causes (e.g., trauma, uveitis, or steroid-induced glaucoma); anterior chamber angle open (grade III or IV gonioscopy); characteristic optic disc changes (e.g., vertical cup-to-disc ratio of Ͼ0.5, disc hemorrhage, or thin or notched neuroretinal rim); and characteristic visual field changes with reference to Anderson's criteria for minimal abnormality in glaucoma. 26 Visual acuity was determined using the Snellen eye chart. IOP and visual field were measured by applanation tonometry and a perimeter (Humphrey Field Analyzer; Carl Zeiss Meditec, Dublin, CA) with the Glaucoma Hemifield Test, respectively. The patients with POAG in this study included those with low-tension glaucoma (LTG) or hightension glaucoma (HTG), but patients with congenital glaucoma or with a family history of glaucoma were excluded. Unrelated control subjects were recruited from people who attended the clinic for conditions other than glaucoma, including senile cataract, floaters, refractive errors, and itchy eyes. Glaucoma was ruled out in the control subjects by the same diagnostic criteria and the same ophthalmic examination as were used in the patients. The patient group was composed of 119 sporadic patients with POAG: 66 males and 53 females, with age at diagnosis ranging from 11 to 86 years (mean Ϯ SD: 55.7 Ϯ 16.7). The IOP at diagnosis ranged from 13 to 58 mm Hg (mean Ϯ SD: 27.3 Ϯ 8.3). Among these 119 patients with POAG, 47 (39.5%) were LTG with IOP less than 22 mm Hg. There were 126 unrelated control subjects, 53 men and 73 women, with age ranging from 50 to 84 years (mean Ϯ SD: 66.4 Ϯ 10.9), and IOP less than 22 mm Hg. All study subjects were given a complete ocular examination. Venous blood was obtained and stored at Ϫ20°C for less than 2 months before DNA extraction. The study protocol was approved by the Ethics Committee for Human Research of the Chinese University of Hong Kong and adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all study subjects after explanation of the nature and possible consequences of the study.
PCR and High-Throughput ConformationSensitive Gel Electrophoresis
Genomic DNA was extracted from 200 L of whole blood by a commercial procedure (Qiamp Blood Kit; Qiagen, Hilden, Germany). All coding sequences of OPTN, including intron-exon boundaries, were screened for sequence alterations using PCR followed by highthroughput conformation-sensitive gel electrophoresis (HTCSGE). 27 PCR was performed on a thermal cycler (model 9700; Applied Biosystems, Foster City, CA), with an initial denaturation step of 12 minutes at 94°C, followed by 35 cycles of 94°C for 40 seconds, a touchdown annealing temperature of 62°C minus 0.2°C per cycle for 1 minute, and 72°C for 40 seconds, and a final extension step of 72°C for 7 minutes. Each 25-L reaction contained 1.5 mM MgCl 2 , 1 U Taq polymerase (AmpliTaq Gold; Applied Biosystems, Inc.), 200 M dNTPs, 1 L genomic DNA, and 400 pM primers. We also screened all DNA samples in this study for MYOC sequence alterations, as described in our previous reports.
18,19
Direct DNA Sequencing
The samples with altered electrophoretic mobility in HTCSGE were sequenced using a cost-saving sequencing protocol 28 on an automated DNA sequencer (model ABI 377XL; Applied Biosystems, Foster City, CA). Sequence data were aligned with sequence-analysis software, (Sequence Navigator, ver. 1.0.1; Applied Biosystems, Inc.) and compared with the published OPTN gene sequence (GenBank accession number AF420371; http://www.ncbi.nlm.nih.gov/Genbank; provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD). A portion of samples not showing altered HTCSGE pattern were also selected at random for direct sequencing to affirm the reliability of the HTCSGE screening procedure.
Statistical Analysis
Statistical analyses were performed on computer (SAS ver. 8.2; SAS Institute, Cary, NC). The 2 test or the Fisher exact test was used to compare the frequencies of various alleles or genotypes between patients and control subjects. P Ͻ 0.05 was considered significant. The confidence intervals for odds ratios (OR) were calculated by the logistic regression method. The Mann-Whitney test was used to test the association between each phenotype variable and the genotype. Multivariate analyses were performed with a logistic regression model to confirm the association between all the phenotype variables and the genotype. All the phenotypes were set as numerical variables, whereas all the genotypes were set as categorical variables (homozygote, 2; heterozygote, 1; wild type, 0). Multiple logistic regression models were built and optimized using a stepwise approach. A final optimal model was determined by balancing the significance of overall model and phenotype variables.
RESULTS
OPTN Variants Detected in the Study Subjects
Sixteen sequence changes were identified in patients and control subjects (Table 1) . Four were missense changes, five were synonymous codon changes, and seven were changes in the noncoding sequences. Apart from T34T, M98K, and R545Q, the other 13 sequence changes were novel. E103D, H486R, V148V, and IVS13ϩ21C3 G were found exclusively in patients, all with adult-onset POAG. However, P199P, T202T, and IVS8ϩ20G3 A were found only in control subjects. M98K was identified from in 34 patients with POAG and 31 control subject, and R545Q in 8 patients and 11 control subjects. Several homozygotes were identified: IVS6-5T3 C and IVS15-48C3 A each in one patient with POAG, and IVS7ϩ24G3 A in one control subject who was a 50-year-old woman. There were three homozygous patients and one homozygous control subject who had M98K (Table 1) .
Distribution of OPTN Variants in POAG Patients and Control Subjects
Allele frequencies of the 16 variants between patients and controls were not significantly different (P Ͼ 0.05), whereas IVS7ϩ24G3 A showed an inclination toward an association with POAG (P ϭ 0.08; Table 2 ). However, IVS7ϩ24G3 A was found to be associated significantly with POAG (P ϭ 0.02; OR 4.12; 95% CI 1.46 -12.68) when comparing the genotypes between two study groups, whereas the genotypes of other variants were not associated with POAG significantly (P Ͼ 0.05; Table 1 ).
Genotype-Phenotype Correlations
While the genotype of IVS7ϩ24G3 A showed a significant association with POAG, univariate analysis showed it was also significantly related to an increased cup-to-disc ratio (P ϭ 0.005; Table 2 ). There was no significant association between IVS7ϩ24G3 A and age at inclusion, age at diagnosis, IOP at inclusion, IOP at diagnosis, or visual acuity. Because some of these phenotype variables may be linked, the relationships between all the phenotypic features and the genotype of IVS7ϩ24G3 A were investigated by stepwise logistic regression analysis. Still, only the cup-to-disc ratio remained independently associated with IVS7ϩ24G3 A (P ϭ 0.02). The model was deemed satisfactory, in that the deviance and Pearson goodness-of-fit statistics were 0.97 and 0.90 respectively, and the likelihood ratio, score, and Wald global model testing statistics were 0.02, 0.04, and 0.07 respectively.
DISCUSSION
Apart from T34T, M98K, and R545Q, which were previously identified in the study by Rezaie et al., 20 13 of the 16 sequence changes found in this study of Chinese subjects were novel.
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E103D, V148V, H486R, and IVS13ϩ21C3 G were detected exclusively in patients with POAG. The four patients with any of these mutations were LTG, with IOP lower than 22 mm Hg in both eyes. IVS7ϩ24G3 A showed a significantly higher frequency in patients with POAG than in control subjects (Table 1) , suggesting it as a glaucoma-associated change. Although V148V is a synonymous codon change, whereas IVS13ϩ21C3 G and IVS7ϩ24G3 A are noncoding sequence alterations, they may affect mRNA stability and protein function, although the mRNA levels are still to be assessed. 29 The two IVS variations may cause splice site alterations thereby changing the OPTN coding sequences. Among these five sequence changes, E103D and H486R are more likely to be disease causing, accounting for 1.6% (2/119) of sporadic patients with POAG in this study. If all five were confirmed causative mutations, they would have affected 14.3% (17/119) of our patients. Meanwhile, all these sequence changes are still to be affirmatively linked with glaucoma by statistics, segregation in families, sequence analysis of relevant cDNA regions, assessment of the level of the mature transcript, or expression studies before they can be concluded as glaucoma-causing mutations.
M98K and R545Q were found to have intriguingly similar frequencies among glaucoma patients and control subjects, although they were reported as glaucoma-causing mutations by Rezaie et al. 20 In our case, M98K was found in 28.6% patients (34/119) and 24.6% control subjects (31/126), or 12.7% (32/252) of normal chromosomes. Both frequencies were higher than in the white population, 20 especially in the control subjects, which was approximately 10 times higher. R545Q was a probable glaucoma-causing mutation detected only in patients with POAG, 20 but it was found in 8.7% (11/26) of our control subjects, or 4.4% (11/252) of normal chromosomes. It is possible M98K and R545Q are common polymorphisms specific in the Chinese population. However, because the range of age in our control group was from 50 to 84 years, it remains possible that a subset may eventually undergo development of glaucoma and consequently affect the results of our statistic analysis. Although large-scale screening is needed to affirm the allelic frequencies of OPTN variants, pathogenic and functional effects of these sequence alterations have to be affirmed by family linkage analysis and expression studies.
It is noteworthy that in our study subjects we did not find E50K (c.458G3 A) and c.691_692insAG, which were reported as disease causing. 20 The identification of a large number of novel sequence variants and the difference in allelic frequencies in our Chinese subjects when compared with the reported study of whites, 20 suggest a different OPTN mutation pattern in Chinese. 30 The phenotype variables in this study including age at diagnosis, IOP at diagnosis, cup-to-disc ratio, and visual acuity were not normally distributed, as verified by the KolmogorovSmirnov test. As a result we used a nonparametric test (i.e., the Mann-Whitney test) rather than a parametric test (e.g., Stu- A. These two analysis methods consistently revealed that IVS7ϩ24G3 A was associated with an increased cup-to-disc ratio, which is one of the major parameters to assess optic nerve damage in patients with POAG.
Although there have been intensive investigations on the genetic basis of POAG, its pathogenesis is still elusive. MYOC was the first identified disease-causing gene for POAG. 11 In our study on the relationship between the MYOC gene and POAG in a Chinese Han population, we found that the T353I mutation was significantly related to an increased risk of POAG. 19 Mutations of MYOC have been detected in many populations, 10, 11, 15, 18, 19 although they accounted for only 2% to 4% of patients with POAG. 15 The OPTN gene is an important causative gene for POAG. 20 Our report enriches the evidence on the relationship between the OPTN gene and POAG because it provides new opportunities for understanding the disease's pathogenesis. It was responsible for only approximately 12% of sporadic patients with POAG who mainly had LTG, according to Rezaie et al. 20 and for between 1.6% to 14% of our patients, 60% of them having HTG. However, because we used HTCSGE to screen for the sequence alterations, it is possible that additional sequence alterations could still be missed. In addition, Copin et al. 31 found that APOE gene interacted with MYOC gene and suggested APOE gene was a potential modifier for POAG. Besides, Torrado et al. 32 reported that the optimedin and myocilin may interact with each other and may be another candidate gene for POAG. None of the study subjects in this present study carry a MYOC mutation that causes glaucoma. We shall in future attempt to conduct MYOC and OPTN mutation analysis in all our available patients with POAG and control subjects for detail statistical analysis of the genotype-phenotype associations after fine division of genotype and phenotype subgroups. The function of OPTN and its role in POAG pathogenesis are not known at this moment, although it is probable that it is a protein that is involved in a number of signal transduction pathways. 22, 24 A study on the interaction between genetic factors and environmental factors would shed new light on the pathogenesis of POAG.
We have shown E103D, H486R, V148V, IVS7ϩ24G3 A, and IVS13ϩ21C3 G are possibly linked with glaucoma. E103D and H486R may alter protein structure, function, or stability, whereas V148V, IVS7ϩ24G3 A, and IVS13ϩ21C3 G may alter mRNA stability. IVS7ϩ24G3 A is associated with an increased cup-to-disc ratio and is potentially related to disruption of optic nerve. These different mechanisms may ultimately affect the normal signal transduction function of OPTN and potentiate optic nerve apoptosis. At the same time, the deregulation of the signal transduction pathway can also be mediated through posttranslational modifications. One likely candidate is phosphorylation, which decreases OPTN half-life. 22 It would be interesting to investigate whether the change in OPTN halflife associates with glaucoma pathogenesis and how this pathway is regulated. It may finally turn out that the upstream regulators of OPTN also play important roles in the pathogenesis of glaucoma.
